Teppei Sakoda1,2, Yoshikane Kikushige1,2, Toshihiro Miyamoto1,3, Koichi Akashi1,2 (1.Dept of Medicine and Biosystemic Science, Kyushu Univ, Fukuoka, Japan, 2.Center for Cellular and Molecular Medicine, Kyushu Univ, Fukuoka, Japan, 3.Dept of Hematology/Oncology/Cardiovascular medicine, Kyushu University Hospital, Fukuoka, Japan)
Session information
Oral Session
Oral Session 3-12B AML: Leukemogenesis
Sun. Oct 13, 2019 10:10 AM - 11:10 AM No.12 (Tokyo International Forum, 5F G510)
Chair: Masahiro Nakagawa (Dept. Pathology and Tumor Biology, Kyoto University, Kyoto, Japan1,)
Masaya Ueno1,2, Yusuke Takase1, Kenta Kurayoshi1, Kumiko Ohta1, Kyoko Fuse1,3, Yuki Nishida4, Kensuke Kojima4, Atsushi Hirao1,2 (1.Cancer Research Institute, Kanazawa University, Ishikawa, Japan, 2.WPI Nano Life Science Institute, Kanazawa University, 3.Dep Hematol, Endocrinol and Metabol, Niigata Univ, 4.Div Hematol, Resp Med, and Oncol, Saga Univ)
Hideaki Mizuno1, Yuki Kagoya1, Junji Koya2, Yosuke Masamoto1, Mineo Kurokawa1 (1.Hematol. and Oncol., Tokyo Univ., Tokyo, Japan, 2.National Cancer Center Japan, Tokyo, Japan)
Yu Kochi1, Yoshikane Kikushige1, Toshihiro Miyamoto1, Koichi Akashi1,2 (1.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 2.Center for Cellular and Molecular Medicine, Kyushu University, Fukuoka, Japan)
Kaoru Yoshida1, Akihiro Watanabe2, Tomoo Osumi1,3, Shunsuke Kimura4, Kazuhiko Nakabayashi5, Hiroko Ogata5, Kohji Okamura6, Ryota Shirai1, Masanori Yoshida1, Shinichi Tsujimoto3, Daisuke Tomizawa3, Hiroyuki Takahashi7, Kimikazu Matsumoto3, Seishi Ogawa8, Nobutaka Kiyokawa1, Susumu Goyama9, Kenichiro Hata5, Motohiro Kato1,3 (1.Department of Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Department of pediatrics, Niigata Cancer Center Hospital, Niigata, Japan, 3.Children's Cancer Center, NCCHD, Tokyo, Japan, 4.Department of Pediatrics, The University of Tokyo, Tokyo, Japan, 5.Department of Maternal-Fetal Biology, NCCHD, Tokyo, Japan, 6.Department of Systems BioMedicine, NCCHD, Tokyo, Japan, 7.Department of Pediatrics, Toho University, Tokyo, Japan, 8.Dept. Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 9.Div. Cellular Therapy, Inst. Medical Science, Univ. Tokyo, Tokyo, Japan)
Masayuki Iwasaki1,2,3, Hiroaki Honda1, Motomi Osato3,4, Michael Cleary2 (1.Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan, 2.Department of Pathology, Stanford University School of Medicine, Stanford, USA, 3.IRCMS, Kumamoto University, Kumamoto, Japan, 4.CSI, National University of Singapore, Singapore)